Evidence map›Paper›PMID 33306332›Full record

ArticleTurkish journal of medical sciences2021

A sensitive indicator for the severity of COVID-19: thiol

Özcan Erel, Salim Neşelioğlu, Merve Ergin Tunçay, Esra Fırat Oğuz, Funda Eren, Meryem Sena Akkuş, Hatice Rahmet Güner, İhsan Ateş

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Thiol-disulphide Homeostasis in Patients with Schizophrenia: The Potential Biomarkers of Oxidative Stress in Acute Exacerbation of Schizophrenia.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19.Advances in pharmacological and pharmaceutical sciences · 2022
    Review
  16. Predicting the Disease Severity of Virus Infection.Advances in experimental medicine and biology · 2022
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Özcan ErelDepartment of Biochemistry, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, TurkeyORCID 0000-0002-2996-3236
Salim NeşelioğluDepartment of Biochemistry, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, TurkeyORCID 0000-0002-0974-5717
Merve Ergin TunçayDepartment of Biochemistry, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, TurkeyORCID 0000-0003-3440-3353
Esra Fırat OğuzCentral Biochemistry Laboratory, Ankara City Hospital, Ankara, TurkeyORCID 0000-0002-8147-5379
Funda ErenCentral Biochemistry Laboratory, Ankara City Hospital, Ankara, TurkeyORCID 0000-0002-8649-2493
Meryem Sena AkkuşCentral Research Laboratory, Yıldırım Beyazıt University, Ankara, TurkeyORCID 0000-0003-2550-550X
Hatice Rahmet GünerDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, TurkeyORCID 0000-0002-1029-1185
İhsan AteşDepartment of Internal Medicine, Ankara City Hospital, Ankara, TurkeyORCID 0000-0003-2858-6229
Memorial Ankara Hospital · TRAnkara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Thiol status is a good reflector of the cellular redox and have vital roles in various cellular signaling pathways. The purpose of the study was to investigate thiol status in patients with SARS-CoV-2 infection. Materials and methods: A total of 587 subjects (517 patients/70 healthy controls) were enrolled in the study.The patients were categorized into the groups regarding to the severity of disease (mild, moderate, severe, and critical).Thiol status of all groups were compared. Results: The patients had significantly diminished thiol levels compared to controls. Thiol levels were gradually decreased as the severity of the disease increased. Logistic regression analyses identified that thiol concentrations were an independent risk factor for the disease severity in each phase (mild group OR 0.975, 95%CI 0.965-0.986; moderate group, OR 0.964, 95%CI 0.953-0.976; severe group OR 0.953, 95%CI 0.941-0.965; critical group OR 0.947, 95%CI 0.935-0.960).Thiol test exhibited the largest area under the curve at 0.949, with the highest sensitivity (98.6%) and specificity (80.4%). Conclusions: Depleted thiol status was observed in SARS-CoV-2 infection. Decline of the thiol levels by degrees while the severity of infection increased was closely related to the progression of the disease. This outcome highlights that thiols could be an impressible biomarker for predicting of the severity of COVID-19.

Indexed as

AgedBiomarkersCOVID-19FemaleFollow-Up StudiesHumansMaleMiddle AgedPandemicsProspective StudiesSARS-CoV-2Severity of Illness IndexSulfhydryl CompoundsBiomarkersSulfhydryl CompoundsCOVID-19immune responseinflammationseveritythiol

Identifiers

PMID33306332
PMCPMC8283472
OpenAlexW3112884023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.